Permanent Gentamicin Vestibulotoxicity
Authors:
- F. Owen BlackFBF. Owen Black
- Susan PeszneckerSPSusan Pesznecker
- Valerie StallingsVSValerie Stallings
- 1 July 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 25 (4) , 559-569
Abstract
To determine the natural history of permanent gentamicin vestibulotoxicity. Retrospective; comparison of retrospective and prospective studies. Tertiary neurotology clinic. Clinical research and technology center. Thirty-three subjects with permanent gentamicin-induced vestibulotoxicity. Medical records review, neurotologic examination, and vestibular and auditory function tests. Vestibular and auditory function test results at least 1 year after discontinuation of gentamicin, clinical examination results, serum gentamicin levels, and serum creatinine levels. Thirty-three subjects had vestibular function test results consistent with permanent gentamicin ototoxicity. All complained of dysequilibrium, 32 described oscillopsia, and 23 had tinnitus. All 33 subjects had complained of symptoms consistent with ototoxicity within 1 to 3 weeks of initiation of gentamicin therapy; however, gentamicin vestibulotoxicity was not recognized before hospital discharge in 32 of 33 subjects. Serum peak and trough gentamicin levels did not correlate with the development of vestibulotoxicity, nor did observance of recommended “safe” dosage ranges. Of 17 subjects whose serum creatinine levels were recorded, 6 experienced abnormal elevations in serum creatinine in conjunction with gentamicin use. Gentamicin can cause permanent vestibular and auditory ototoxicity. There is no safe dose of gentamicin. Serum gentamicin levels are of no value in predicting the onset, occurrence, or severity of vestibulotoxicity or cochleotoxicity. Termination of gentamicin on appearance of signs or symptoms of ototoxicity may reduce the incidence of permanent vestibular ototoxicity. When possible, other antibiotics should be administered.Keywords
This publication has 26 references indexed in Scilit:
- World Medical Association Declaration of HelsinkiJAMA, 2000
- Unilateral Vestibulotoxicity Due to Systemic Gentamicin TherapyActa Oto-Laryngologica, 1998
- A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided dosesJournal of Antimicrobial Chemotherapy, 1996
- Gentamicin once-daily versus thrice-daily in childrenJournal of Antimicrobial Chemotherapy, 1995
- Predictive Monitoring of High-frequency Vestibulo-ocular Reflex Rehabilitation Following Gentamicin OtotoxicityActa Oto-Laryngologica, 1995
- Gentamicin vestibulotoxicityOtolaryngology–Head and Neck Surgery, 1994
- Otoacoustic emissions: An approach for monitoring aminoglycoside‐induced ototoxicityThe Laryngoscope, 1994
- Clinical monitoring using otoacoustic emissionsBritish Journal of Audiology, 1993
- Vestibular reflex changes following aminoglycoside induced ototoxicityThe Laryngoscope, 1987
- AMINOGLYCOSIDE OTOTOXICITY IN THE HUMANThe Laryngoscope, 1980